Fund profile · Compiled from public sources

LYZZ Capital

Shanghai, China

Their stated focus (public profile)

LYZZ Capital is a healthcare-dedicated VC/PE firm investing globally across USD and RMB funds totaling over $600 million. The team focuses on pharmaceuticals and biotech, with an emphasis on unmet medical needs and large market potential in China. They invest in talents, assets, and technologies globally, drawing on over 20 years of biotech investment experience.

Sectors: Healthtech, Life sciences

Website: lyzzcap.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →